Breaking News, Promotions & Moves

ACG Appoints Latit Kasliwal as Group CFO

Kasliwal brings 27+ years of global leadership experience in financial strategy, treasury, capital allocation and structuring, governance, enterprise transformation and risk management.

Author Image

By: Charlie Sternberg

Associate Editor

Latit Kasliwal.

ACG has appointed Lalit Kasliwal as Group Chief Financial Officer (CFO), where he will lead ACG’s global finance function, driving financial strategy, treasury, governance, capital allocation and risk management to support the Group’s long-term ambitions.

Karan Singh, Managing Director at ACG, said, “We are delighted to welcome Lalit to ACG. He brings a wealth of global experience, a strong track record of financial leadership and a deep understanding of complex international businesses. His expertise will be invaluable as we continue to strengthen our operations and pursue the next phase of our growth strategy.”

Experience

Kasliwal brings more than 27 years of global leadership experience in financial strategy, treasury, capital allocation and structuring, governance, enterprise transformation and risk management across the pharmaceutical, manufacturing and international trading sectors.

He joins ACG from Tata International Limited, where he served as Chief Financial Officer and Company Secretary, leading the global finance function for operations across more than 29 countries. Prior to this, he served as CFO – Group Manufacturing and Head of Group Insurance at Reliance Industries Limited. Earlier in his career, he held senior finance leadership positions with Vedanta Group (Hindustan Zinc Limited and Sterlite Technologies Limited), Ruia Group and IPCA Laboratories Limited.

“I am delighted to be joining ACG at an exciting stage of its global growth journey,” Kasliwal remarked. “I look forward to partnering with colleagues across the organization to strengthen financial performance, enhance governance and support sustainable long-term value creation for our customers, partners and stakeholders.”

More ACG News

This appointment comes as ACG continues to expand its global presence and invest in technologies and solutions that support pharmaceutical and nutraceutical manufacturers worldwide. In October, the company announced plans to invest $200 million to establish empty-capsule manufacturing operations in the U.S.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters